Intuitive Surgical (NASDAQ:ISRG – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday.
Several other equities research analysts have also issued reports on ISRG. Rothschild & Co Redburn increased their target price on shares of Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Mizuho set a $575.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Daiwa Capital Markets lifted their target price on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Finally, Royal Bank Of Canada set a $625.00 target price on shares of Intuitive Surgical and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $607.17.
Check Out Our Latest Stock Report on Intuitive Surgical
Intuitive Surgical Stock Performance
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter in the prior year, the business posted $1.84 earnings per share. The business’s quarterly revenue was up 22.9% on a year-over-year basis. Analysts predict that Intuitive Surgical will post 6.43 EPS for the current year.
Insiders Place Their Bets
In other Intuitive Surgical news, insider Gary S. Guthart sold 22,806 shares of the stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $570.89, for a total transaction of $13,019,717.34. Following the completion of the transaction, the insider owned 2,694 shares of the company’s stock, valued at $1,537,977.66. This represents a 89.44% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 105 shares of Intuitive Surgical stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $560.00, for a total value of $58,800.00. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 108,939 shares of company stock worth $60,757,995. 0.70% of the stock is owned by corporate insiders.
Institutional Trading of Intuitive Surgical
Hedge funds have recently modified their holdings of the company. Aaron Wealth Advisors LLC raised its stake in Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after purchasing an additional 19 shares in the last quarter. Prosperity Consulting Group LLC grew its stake in shares of Intuitive Surgical by 0.5% in the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after buying an additional 19 shares in the last quarter. Exencial Wealth Advisors LLC increased its holdings in shares of Intuitive Surgical by 3.1% in the 1st quarter. Exencial Wealth Advisors LLC now owns 661 shares of the medical equipment provider’s stock worth $327,000 after buying an additional 20 shares during the last quarter. Evergreen Capital Management LLC increased its holdings in shares of Intuitive Surgical by 0.5% in the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock worth $2,124,000 after buying an additional 20 shares during the last quarter. Finally, Rise Advisors LLC raised its position in shares of Intuitive Surgical by 5.6% during the 1st quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock valued at $187,000 after buying an additional 20 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Rocket Lab’s Big Rebound? Analysts Suggest the Dip’s a Gift
- What is a Stock Market Index and How Do You Use Them?
- Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish
- What Are Trending Stocks? Trending Stocks Explained
- Snowflake Stock: The Dip That Smart Investors Are Buying Right Now
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
